mitomycin has been researched along with Body Weight in 46 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of this study was to investigate the effectiveness of Mitomycin C (MMC), which inhibits fibroblastic proliferation in preventing caustic esophageal strictures." | 3.73 | Mitomycin C prevents strictures in caustic esophageal burns in rats. ( Başaklar, AC; Demirtola, A; Dinçer, S; Gülen, S; Kale, N; Karabulut, R; Poyraz, A; Sönmez, K; Türkyilmaz, Z, 2005) |
| "Chuling (Polyporus umbellatus), one of the commonly used Chinese medical herbs, was combined with mitomycin C and then studied against intrahepatic implantation of sarcoma 180 tumor cells in mice." | 3.69 | Combined effects of chuling (Polyporus umbellatus) extract and mitomycin C on experimental liver cancer. ( Chen, KT; Hau, DM; Huang, HF; You, JS, 1994) |
| "The water-soluble conjugates of mitomycin C (MMC) with N-succinyl-chitosan (N-Suc-chitosan) and glycol-chitosan (Gly-chitosan), named N-Suc-chitosan-glu-MMC and Gly-chitosan-glu-MMC, respectively, were characterized mainly by the plasma concentration-time profiles of MMC after intraperitoneal administration and their in vivo antitumor effect against P388 leukemia and Sarcoma 180." | 3.69 | In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan. ( Machida, Y; Nagai, T; Onishi, H; Sato, M; Takahara, J, 1996) |
| "In this study, norcantharidin was compared with adriamycin and mitomycin C for its inhibitory action in the growth of cultured human hepatocellular carcinoma HepG2 cells." | 3.69 | Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. ( Cheng, LY; Mack, PO; Tang, WY; Yang, EB; Zhang, K, 1997) |
| " Furthermore, the survival was elevated in proportion to the increase of total dosage of futraful." | 2.65 | [Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)]. ( Abe, O; Akiyama, H; Hattori, T; Hayasaka, A; Inokuchi, K; Inoue, K; Ito, I; Kasai, Y; Kikuchi, K; Kondo, T; Muto, T; Nakajima, T; Sugie, S; Taguchi, T, 1982) |
| " MMC microspheres, alone or combined with Dox microspheres, were injected i." | 1.33 | In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations. ( Cheung, RY; Rauth, AM; Yu Wu, X, 2005) |
| "Mice bearing sarcoma 180 tumors were used as an in vivo model." | 1.32 | Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. ( Akaike, T; Fang, J; Greish, K; Maeda, H; Sawa, T, 2004) |
| "The antitumor and toxic side effects of mitomycin C-estradiol conjugates (EB-glu-MMC and E-glu-MMC) were evaluated in detail for solutions in propylene glycol and suspensions in 10% (v/v) propylene glycol." | 1.32 | Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates. ( Ishiki, N; Machida, Y; Onishi, H, 2004) |
| "Marimastat seems to be a candidate for the prevention of peritoneal spread of gastric carcinoma." | 1.31 | Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice. ( Fujii, M; Igarashi, N; Kameyama, K; Kimata, M; Kitajima, M; Kubota, T; Kumai, K; Okada, Y; Otani, Y; Wada, N; Yokoyama, T; Yoshimizu, N, 2002) |
| " By the use of 3 % gelatin solution, mean residence time (MRT) and Tmax values were significantly prolonged, and Cmax was decreased as compared with the administration of MMC solution." | 1.30 | Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice. ( Fujita, T; Muranishi, S; Tamura, T; Yamada, H; Yamamoto, A, 1997) |
| "Mitomycin C (MC) is an antibiotic that affects DNA synthesis." | 1.30 | Spermatogenic cell apoptosis induced by mitomycin C in the mouse testis. ( Fujioka, M; Mori, C; Nakagawa, S; Nakamura, N, 1997) |
| " To explain this tumor selectivity, the distribution of FK317 was investigated after dosing tumor-bearing mice with the 14C-labelled compound." | 1.30 | FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice. ( Fujiwara, T; Inami, M; Kawamura, I; Manda, T; Matsumoto, S; Naoe, Y; Nishigaki, F; Shimomura, K; Takagaki, S; Tsujimoto, S; Yamazaki, S, 1998) |
| "5 mg/kg), or cisplatin (4 mg/kg, by one shot) to TNP (120-140 mg/kg) with a 6-7 fractionated dosing schedule reduced s." | 1.29 | Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. ( Kakinuma, H; Kato, T; Matsuda, Y; Sato, K, 1994) |
| " Dosing schedules were based on those commonly used in the clinic, and bladder function was assessed from changes in urination frequency." | 1.29 | Bladder damage in mice after single and repeated intravesical instillations of mitomycin C or doxorubicin. ( Oussoren, Y; Post, JG; Stewart, FA; te Poele, JA, 1993) |
| "once weekly for 20 wk to induce colon cancer." | 1.28 | Reduced growth rate of dimethylhydrazine-induced colon tumors in rats. ( Koike, T; Shibusawa, M; Tsunoda, A; Tsunoda, Y; Yasuda, N, 1992) |
| " On the other hand, the increase of the solid tumor weight in the every day treatment and in the every 7th day treatment of hEGF, in combination with the every 7th day administration of MMC, were as follows; from 282 +/- 41 mg to 1522 +/- 357 mg (71." | 1.28 | Response of A431 experimental human solid xenograft to mitomycin C in combination with human epidermal growth factor in mice. ( Amagase, H; Fuwa, T; Hashimoto, K; Murakami, T; Tamura, K; Yata, N, 1990) |
| " These results indicate that JTX enhances the anti-tumor activity of MMC and lessens the adverse effects of it." | 1.27 | Protective effects of juzentaihoto, dried decoctum of 10 Chinese herbs mixture, upon the adverse effects of mitomycin C in mice. ( Aburada, M; Hosoya, E; Ito, E; Nakamura, M; Takeda, S, 1983) |
| "(3) Mitomycin C treated group (MMC: active control) and (4) plasma exchange + MMC treated group (combination therapy)." | 1.27 | [A basic study on plasma exchange therapy of malignant tumor in tumor bearing rats]. ( Suzuki, M, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (23.91) | 18.7374 |
| 1990's | 20 (43.48) | 18.2507 |
| 2000's | 9 (19.57) | 29.6817 |
| 2010's | 6 (13.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, Z | 1 |
| Zou, S | 1 |
| Lu, C | 1 |
| Wu, B | 1 |
| Huang, K | 1 |
| Zhao, C | 1 |
| He, X | 1 |
| Shimada, K | 1 |
| Yamamoto, M | 1 |
| Takashima, M | 1 |
| Wako, Y | 1 |
| Kawasako, K | 1 |
| Aoki, Y | 1 |
| Seki, J | 1 |
| Miyamae, Y | 1 |
| Wakata, A | 1 |
| Azzarà, A | 1 |
| Pirillo, C | 1 |
| Giovannini, C | 1 |
| Federico, G | 1 |
| Scarpato, R | 1 |
| Gupta, N | 1 |
| Noël, R | 1 |
| Goudet, A | 1 |
| Hinsinger, K | 1 |
| Michau, A | 1 |
| Pons, V | 1 |
| Abdelkafi, H | 1 |
| Secher, T | 1 |
| Shima, A | 1 |
| Shtanko, O | 1 |
| Sakurai, Y | 1 |
| Cojean, S | 1 |
| Pomel, S | 1 |
| Liévin-Le Moal, V | 1 |
| Leignel, V | 1 |
| Herweg, JA | 1 |
| Fischer, A | 1 |
| Johannes, L | 1 |
| Harrison, K | 1 |
| Beard, PM | 1 |
| Clayette, P | 1 |
| Le Grand, R | 1 |
| Rayner, JO | 1 |
| Rudel, T | 1 |
| Vacus, J | 1 |
| Loiseau, PM | 1 |
| Davey, RA | 1 |
| Oswald, E | 1 |
| Cintrat, JC | 1 |
| Barbier, J | 1 |
| Gillet, D | 1 |
| Promkum, C | 2 |
| Kupradinun, P | 2 |
| Tuntipopipat, S | 2 |
| Butryee, C | 2 |
| Kimata, M | 1 |
| Otani, Y | 1 |
| Kubota, T | 1 |
| Igarashi, N | 1 |
| Yokoyama, T | 1 |
| Wada, N | 1 |
| Yoshimizu, N | 1 |
| Fujii, M | 1 |
| Kameyama, K | 1 |
| Okada, Y | 1 |
| Kumai, K | 1 |
| Kitajima, M | 1 |
| MATSUYAMA, M | 1 |
| SUZUMORI, K | 1 |
| NAKAMURA, T | 1 |
| EVANS, JS | 1 |
| BOSTWICK, L | 1 |
| MENGEL, GD | 1 |
| Fang, J | 1 |
| Sawa, T | 1 |
| Akaike, T | 1 |
| Greish, K | 1 |
| Maeda, H | 1 |
| Ishiki, N | 1 |
| Onishi, H | 2 |
| Machida, Y | 2 |
| Türkyilmaz, Z | 1 |
| Sönmez, K | 1 |
| Demirtola, A | 1 |
| Karabulut, R | 1 |
| Poyraz, A | 1 |
| Gülen, S | 1 |
| Dinçer, S | 1 |
| Başaklar, AC | 1 |
| Kale, N | 1 |
| Cheung, RY | 1 |
| Rauth, AM | 1 |
| Yu Wu, X | 1 |
| Pelz, JO | 1 |
| Doerfer, J | 1 |
| Hohenberger, W | 1 |
| Meyer, T | 1 |
| Aarts, F | 1 |
| Hendriks, T | 1 |
| Boerman, OC | 1 |
| Koppe, MJ | 1 |
| Oyen, WJ | 1 |
| Bleichrodt, RP | 1 |
| Aburada, M | 1 |
| Takeda, S | 1 |
| Ito, E | 1 |
| Nakamura, M | 1 |
| Hosoya, E | 1 |
| Tamai, K | 1 |
| Nakao, J | 1 |
| Nakagawa, K | 1 |
| Watanabe, K | 1 |
| Sakashita, H | 1 |
| Nishiwaki, Y | 1 |
| Nakashin, T | 1 |
| Kasai, Y | 1 |
| Inokuchi, K | 1 |
| Hattori, T | 1 |
| Inoue, K | 1 |
| Taguchi, T | 3 |
| Kondo, T | 1 |
| Akiyama, H | 1 |
| Abe, O | 1 |
| Ito, I | 1 |
| Nakajima, T | 1 |
| Muto, T | 1 |
| Kikuchi, K | 1 |
| Sugie, S | 1 |
| Hayasaka, A | 1 |
| Kato, T | 1 |
| Sato, K | 1 |
| Kakinuma, H | 1 |
| Matsuda, Y | 1 |
| Konno, H | 3 |
| Tanaka, T | 3 |
| Matsuda, I | 1 |
| Kanai, T | 2 |
| Maruo, Y | 1 |
| Nishino, N | 1 |
| Nakamura, S | 4 |
| Baba, S | 1 |
| Futamura, Y | 1 |
| Matsumoto, K | 2 |
| You, JS | 2 |
| Hau, DM | 2 |
| Chen, KT | 1 |
| Huang, HF | 1 |
| Fujita, M | 2 |
| Fujita, F | 1 |
| Inaba, H | 1 |
| Post, JG | 1 |
| te Poele, JA | 1 |
| Oussoren, Y | 1 |
| Stewart, FA | 1 |
| Chen, TH | 1 |
| Cheng, JF | 1 |
| Cullen, MH | 1 |
| Sato, M | 1 |
| Takahara, J | 1 |
| Nagai, T | 1 |
| Fujita, T | 1 |
| Tamura, T | 1 |
| Yamada, H | 1 |
| Yamamoto, A | 1 |
| Muranishi, S | 1 |
| Yang, EB | 1 |
| Tang, WY | 1 |
| Zhang, K | 1 |
| Cheng, LY | 1 |
| Mack, PO | 1 |
| Nakagawa, S | 1 |
| Nakamura, N | 1 |
| Fujioka, M | 1 |
| Mori, C | 1 |
| Naoe, Y | 2 |
| Kawamura, I | 2 |
| Inami, M | 2 |
| Matsumoto, S | 2 |
| Nishigaki, F | 2 |
| Tsujimoto, S | 2 |
| Manda, T | 2 |
| Shimomura, K | 2 |
| Takagaki, S | 1 |
| Fujiwara, T | 1 |
| Yamazaki, S | 1 |
| Baba, M | 2 |
| Kamiya, K | 2 |
| Ohba, K | 1 |
| Ohta, M | 1 |
| Oba, K | 1 |
| Kaneko, T | 1 |
| Syouji, T | 1 |
| Igarashi, A | 1 |
| Shrestha, RD | 1 |
| Fujimoto, S | 1 |
| Okui, K | 1 |
| Tsunoda, A | 1 |
| Shibusawa, M | 1 |
| Tsunoda, Y | 1 |
| Yasuda, N | 1 |
| Koike, T | 1 |
| Salm, R | 1 |
| Wullich, B | 1 |
| Kiefer, G | 1 |
| Fiebig, HH | 1 |
| Farthmann, EH | 1 |
| Kusuyama, T | 1 |
| Okuyama, Y | 1 |
| Amagase, H | 1 |
| Tamura, K | 1 |
| Hashimoto, K | 1 |
| Fuwa, T | 1 |
| Murakami, T | 1 |
| Yata, N | 1 |
| Tsuruo, T | 1 |
| Sudo, Y | 1 |
| Asami, N | 1 |
| Inaba, M | 1 |
| Morimoto, M | 1 |
| Borgeson, CE | 1 |
| Pardini, L | 1 |
| Pardini, RS | 1 |
| Reitz, RC | 1 |
| Yoneda, T | 1 |
| Nojima, Y | 1 |
| Nagai, A | 1 |
| Nagasawa, M | 1 |
| Nishio, Y | 1 |
| Suzuki, M | 1 |
| Bregman, CL | 1 |
| Comereski, CR | 1 |
| Buroker, RA | 1 |
| Hirth, RS | 1 |
| Madissoo, H | 1 |
| Hottendorf, GH | 1 |
| Finkelstein, DM | 1 |
| Ettinger, DS | 1 |
| Ruckdeschel, JC | 1 |
| Marchiondo, AA | 1 |
| Andersen, FL | 1 |
2 trials available for mitomycin and Body Weight
| Article | Year |
|---|---|
[Effect of postoperative long-term chemotherapy of stomach cancer using mitomycin C and futraful--the secondary study (1)].
Topics: Aged; Antibiotics, Antineoplastic; Blood Cell Count; Body Weight; Clinical Trials as Topic; Drug The | 1982 |
Mitomycin, ifosfamide, and cisplatin in non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell | 1993 |
44 other studies available for mitomycin and Body Weight
| Article | Year |
|---|---|
Evaluation of the effects of feeding glyphosate-tolerant soybeans (CP4 EPSPS) on the testis of male Sprague-Dawley rats.
Topics: Animal Feed; Animals; Behavior, Animal; Body Weight; Glycine; Glycine max; Glyphosate; Herbicide Res | 2019 |
Repeated-dose liver micronucleus assay of mitomycin C in young adult rats.
Topics: Age Factors; Animals; Biomarkers; Body Weight; Bone Marrow; Carcinogens; Chromosome Aberrations; Coo | 2015 |
Different repair kinetic of DSBs induced by mitomycin C in peripheral lymphocytes of obese and normal weight adolescents.
Topics: Body Mass Index; Body Weight; Cell Culture Techniques; Cells, Cultured; Child; DNA Breaks, Double-St | 2016 |
Inhibitors of retrograde trafficking active against ricin and Shiga toxins also protect cells from several viruses, Leishmania and Chlamydiales.
Topics: Animals; Benzamides; Body Weight; Chlamydiales; Ebolavirus; Escherichia coli; HEK293 Cells; HeLa Cel | 2017 |
Nutritive evaluation and effect of Moringa oleifera pod on clastogenic potential in the mouse.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkylating Agents; Animals; Antioxidants; Body Weight; Carcinogens | 2010 |
Anticlastogenic effect of Eryngium foetidum L. assessed by erythrocyte micronucleus assay.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimutagenic Agents; Body Weight; Dose-Response Relation | 2012 |
Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Body Weight; Cell Survival; Coloring Ag | 2002 |
INDUCTION OF HYDRONEPHROSIS BY PROLONGED INTRAPERITONEAL INJECTIONS OF SUB-TOXIC DOSE OF MITOMYCIN C IN MICE.
Topics: Ascites; Body Weight; Hydronephrosis; Hydrothorax; Injections, Intraperitoneal; Kidney; Liver; Lung; | 1964 |
SYNERGISM OF THE ANTINEOPLASTIC ACTIVITY OF CYTOSINE ARABINOSIDE BY PORFIROMYCIN.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cytarabine; Cytosine; Leukemia; | 1964 |
Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.
Topics: Animals; Annexin A5; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Body Weigh | 2004 |
Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Chromatography, High Pressure Liquid; Estradiol; | 2004 |
Mitomycin C prevents strictures in caustic esophageal burns in rats.
Topics: Alkalies; Animals; Antibiotics, Antineoplastic; Body Weight; Burns, Chemical; Disease Models, Animal | 2005 |
In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Delayed-Action Preparations; D | 2005 |
A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis.
Topics: Animals; Body Weight; Cell Line, Tumor; Combined Modality Therapy; Dose-Response Relationship, Drug; | 2005 |
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Body Weight; Colonic Neoplasms; Combin | 2007 |
Protective effects of juzentaihoto, dried decoctum of 10 Chinese herbs mixture, upon the adverse effects of mitomycin C in mice.
Topics: Animals; Body Weight; Drug Interactions; Drugs, Chinese Herbal; Leukemia P388; Leukopenia; Male; Mic | 1983 |
Antitumor activity in the culture supernatant fluid of Fusobacterium nucleatum strain KO-31.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Ehrlich Tumor; Culture Media; Female; Fusoba | 1983 |
Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; C | 1994 |
Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Cell Division; Colonic Neoplasms; Cyclohexanes; H | 1995 |
Characteristics of peripheral blood monocytes and bone marrow macrophages from rats treated with mitomycin C, 5-fluorouracil or phenylhydrazine.
Topics: Animals; Blood Cell Count; Body Weight; Bone Marrow; Bone Marrow Cells; Cell Movement; Fluorouracil; | 1995 |
Combined effects of chuling (Polyporus umbellatus) extract and mitomycin C on experimental liver cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Body Wei | 1994 |
[Antitumor activity of LY 188011, a new deoxycytidine analog, against human cancers xenografted into nude mice].
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Colonic Neoplasms; Deoxycytidine; Drug Admini | 1994 |
Bladder damage in mice after single and repeated intravesical instillations of mitomycin C or doxorubicin.
Topics: Administration, Intravesical; Animals; Body Weight; Dose-Response Relationship, Drug; Doxorubicin; D | 1993 |
Combined therapy of mitomycin C and Chinese medical herbs on experimental liver cancer.
Topics: Animals; Body Weight; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combinatio | 1993 |
In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan.
Topics: Animals; Antibiotics, Antineoplastic; Biopolymers; Body Weight; Chemical Phenomena; Chemistry, Physi | 1996 |
Pharmacokinetics of mitomycin C (MMC) after intraperitoneal administration of MMC-gelatin gel and its anti-tumor effects against sarcoma-180 bearing mice.
Topics: Animals; Antibiotics, Antineoplastic; Body Weight; Gelatin; Gels; Injections, Intraperitoneal; Male; | 1997 |
Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival.
Topics: Animals; Antineoplastic Agents; Body Weight; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hep | 1997 |
Spermatogenic cell apoptosis induced by mitomycin C in the mouse testis.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Body Weight; DNA; DNA Fragmentation; Immunohistoche | 1997 |
Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice.
Topics: Adenocarcinoma; Adipose Tissue; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Blood G | 1998 |
FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biotransformation; Body Weight; Carcinoma, Large Cel | 1998 |
Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.
Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Body Weight; Cell Divi | 2000 |
Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; C | 2001 |
A novel anticancer treatment for xenoplanted human gastric cancer using polyamine antimetabolites in a low polyamine diet.
Topics: Adenosylmethionine Decarboxylase; Animals; Body Weight; Cell Division; Combined Modality Therapy; Di | 1992 |
Reduced growth rate of dimethylhydrazine-induced colon tumors in rats.
Topics: Animals; Body Weight; Cell Division; Colonic Neoplasms; Dimethylhydrazines; Eflornithine; Male; Mito | 1992 |
Effects of a three-drug antineoplastic protocol of wound healing in rats: a biomechanical and histologic study on gastrointestinal anastomoses and laparotomy wounds.
Topics: Anastomosis, Surgical; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Doxorub | 1991 |
[Experimental studies on subrenal capsule assay using cyclosporin A treated mice--the optimal treatment schedules of CsA and anticancer agents (mitomycin C and 5-fluorouracil)].
Topics: Animals; Body Weight; Breast Neoplasms; Colonic Neoplasms; Cyclosporins; Female; Fluorouracil; Human | 1990 |
Response of A431 experimental human solid xenograft to mitomycin C in combination with human epidermal growth factor in mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Drug Administration Schedule; Drug Therapy, Combination | 1990 |
Antitumor activity of a derivative of mitomycin, 7-N-[2-[[2-(gamma-L-glutamylamino)ethyl]dithio]ethyl]mitomycin C (KW-2149), against murine and human tumors and a mitomycin C-resistant tumor in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Colonic Neoplasms; Drug Screening Assay | 1990 |
Effects of dietary fish oil on human mammary carcinoma and on lipid-metabolizing enzymes.
Topics: Acyltransferases; Animals; Body Weight; Carnitine Acyltransferases; Dietary Fats, Unsaturated; Doxor | 1989 |
[Toxicity studies on T-3262 in rat upon intravenous injection for 14 days].
Topics: Animals; Anti-Infective Agents; Body Weight; Bone Marrow; Drinking; Eating; Fluoroquinolones; Hemato | 1989 |
[A basic study on plasma exchange therapy of malignant tumor in tumor bearing rats].
Topics: Animals; Body Weight; Liver Neoplasms, Experimental; Mitomycin; Mitomycins; Orosomucoid; Plasmaphere | 1986 |
Single-dose and multiple-dose intravenous toxicity studies of BMY-25282 in rats.
Topics: Animals; Arteritis; Blood; Body Weight; Creatine Kinase; Digestive System; Female; Heart; Kidney; Ki | 1987 |
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Wei | 1986 |
In vivo efficacy and ultrastructural effects of mitomycin C against experimental alveolar hydatid disease.
Topics: Animals; Arvicolinae; Body Weight; Drug Evaluation, Preclinical; Echinococcosis; Echinococcus; Femal | 1985 |